Alfa Chemistry Newly Introduces Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Alfa Chemistry, a leading pharmaceutical supplier, has recently announced the addition of three new APIs to its full-ranged product catalog, i.e., tofacitinib citrate, tamoxifen citrate, and epalrestat. These new products are introduced to meet the growing demands of the pharmaceutical market.

Tofacitinib Citrater
Tofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by suppressing the immune system and reducing inflammation in the body. Tofacitinib Citrate is a selective inhibitor of Janus kinase (JAK) enzymes, which play a key role in immune response and inflammatory signaling. Alfa Chemistry offers tofacitinib citrate as active pharmaceutical ingredients in various purities and quantities to meet the specific requirements of different research projects. The product is manufactured using advanced technology and under strict quality control procedures to ensure its safety and effectiveness.

Tamoxifen Citrater
Tamoxifen Citrate is a medication used to treat breast cancer and prevent its recurrence. It works by blocking the effects of estrogen on breast tissue, which can promote the growth of cancer cells. Tamoxifen Citrate is also used for some other medical purposes. Alfa Chemistry offers tamoxifen citrate as active pharmaceutical ingredients in various purities and quantities to meet the specific needs of different research projects. Like all other chemicals provided by Alfa Chemistry, this product is also manufactured using advanced technology and under strict quality control procedures to ensure its safety and effectiveness.

Epalrestatr
Epalrestat is used to treat diabetic neuropathy, a condition that affects millions of people worldwide. By providing high-quality epalrestat as active pharmaceutical ingredients, Alfa Chemistry is supporting the development of better treatments for this condition and helping to improve the quality of life for people living with diabetes.

“Researchers and pharmaceutical companies can now turn to us for high-quality APIs to help advance the treatment of various medical conditions. With innovative solutions and excellent customer service, Alfa Chemistry is well-positioned to become a leading supplier in the pharmaceutical industry,” commented the Marketing Chief of Alfa Chemistry.

For more information, please visit https://alfa-api.com/ or email us directly.